by Elie Khalife, president, KeyCentrix
Data has always been a part of the healthcare ecosystem. Although it’s been collected inconsistently in the past, technology has helped advance the gathering, storing and needs for this data today. For decades healthcare professionals had worked independently to collect and aggregate data, but the calling for advancements in the healthcare industry required better interaction for all of healthcare’s actors including, but not limited to, drug manufacturers, prescribers, pharmacies and patients. Continuous improvements in technology facilitated and promoted this collaboration while providing even better outcomes for the industry and patients alike. These advancements and outcomes in healthcare now grow exponentially, and patient data is the new driving force.
The Need for Data
In 1972, with the distribution of methadone, the first drug was required to have data tracking and controlled distribution from the Food and Drug Administration (FDA). Now fast forward to 2005, an interesting year for drugs and pharmacies in general, the FDA started to demand more data points from drug manufacturers regarding new drug therapies in clinical trials and maintaining patents for existing blockbuster drugs. In turn, drug manufacturers required more process controls and limited the distribution to a select number of pharmacy locations that were capable of handling the collection of the expected data needed. This started a new trend of limited distribution drugs (LLD’s)